Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Institute of Microbiology Group is a Guangzhou-based state-owned microbiology and life-science services organization that evolved from the original Guangzhou Institute of Microbiology founded in 1972. The group focuses on microbiology testing, certification, metrology, biosafety and toxicology evaluation, fermentation and strain-related technical services, and selected biopharma and healthcare support services. Its service portfolio spans disinfectants, medical devices, biologics, enzyme products, cleanroom and hospital environmental monitoring, virus inactivation testing, animal studies, and gut-health related microbiome services. The company appears to operate primarily as a commercial testing and technical services platform rather than as a therapeutics developer, with broad capabilities across product quality, compliance, and translational microbiology support for healthcare and industrial customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Institute of Microbiology Group.